✦ LIBER ✦

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial

✍ Scribed by Barnett, Anthony H; Mithal, Ambrish; Manassie, Jenny; Jones, Russell; Rattunde, Henning; Woerle, Hans J; Broedl, Uli C

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the p38 MAPK inhi

✍ Watz, Henrik; Barnacle, Helen; Hartley, Benjamin F; Chan, Robert 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 405 KB

Efficacy and safety of the dipeptidyl pe

✍ Pratley, Richard E.; Reusch, Jane E.-B.; Fleck, Penny R.; Wilson, Craig A.; Mekk 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 282 KB

Efficacy and safety of alogliptin added

✍ K. Kaku; T. Itayasu; S. Hiroi; M. Hirayama; Y. Seino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Efficacy and safety of alogliptin added

✍ Y. Seino; Y. Miyata; S. Hiroi; M. Hirayama; K. Kaku 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Efficacy and safety of alogliptin added

✍ Seino, Yutaka; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 270 KB

Efficacy and tolerability of sitagliptin

✍ Barzilai, Nir; Guo, Hua; Mahoney, Erin M.; Caporossi, Suzanne; Golm, Gregory T.; 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 259 KB